A. Olivier

发表

Stereoelectronic properties of five anti-HSV-1 2'-deoxynucleosides analogues with heterocyclic substituents in the 5-position: a comparison with BVDU.

P. Herdewijn, A. Van Aerschot, F. Durant, 1994, Antiviral research.

Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.

M. Castel, P. Barnéoud, T. Rooney, 2019, Bioorganic & medicinal chemistry letters.

The discovery of AZD0530: a novel, oral, highly selective and dual-specific inhibitor of the Src and Abl family kinases

R. Morgentin, P. Plé, L. Hennequin, 2005 .

Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket.

Andrew G. Leach, Paul D. Johnson, R. Morgentin, 2006, Bioorganic & medicinal chemistry letters.

Inhibitors of leukotriene B4. Synthesis and sar of new ß-enaminoester open-chain analogues of zeneca ZD2138

A. Olivier, T. Geoffrey, C. Bird, 1996 .

Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket.

Paul D. Johnson, R. Morgentin, R. Bradbury, 2006, Bioorganic & medicinal chemistry letters.

New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino)quinazolines as potent and selective c-Src kinase inhibitors.

B. Barlaam, R. Morgentin, P. Plé, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of cephalosporins with C-3' catechol-containing residues.

T. G. Bird, J. P. Bailey, F. Jung, 1992, Journal of Medicinal Chemistry.

Relationship between structural properties and affinity for herpes simplex virus type 1 thymidine kinase of bromine substituted 5-heteroaromatic 2'-deoxyuridines.

P. Herdewijn, A. Van Aerschot, F. Durant, 1996, Antiviral research.

5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase.

Paul D. Johnson, R. Morgentin, R. Bradbury, 2005, Bioorganic & medicinal chemistry letters.

Synthesis of prostanoic acid

W. Pilgrim, A. Olivier, A. Hamon, 1976 .

5-(thien-2-yl) uracil analogs: 5-(5-methylthien-2-yl)-2′-deoxyuridine, 5-(5-thien-2-yl)-2′-deoxyuridine, and 5-(5-bromothien-2-yl)-2′-deoxyuridine

P. Herdewijn, B. Norberg, F. Durant, 1996 .

Inhibitors of the Tyrosine Kinase EphB4. Part 3. Identification of Non-benzodioxole-Based Kinase Inhibitors.

D. Cross, B. Barlaam, R. Ducray, 2011 .

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Ducray, 2008, Bioorganic & medicinal chemistry letters.

N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor.

L. Otterbein, J. Breed, R. A. Norman, 2006, Journal of medicinal chemistry.

Inhibitors of the tyrosine kinase EphB4. Part 3: identification of non-benzodioxole-based kinase inhibitors.

D. Cross, B. Barlaam, R. Ducray, 2010, Bioorganic & medicinal chemistry letters.

Strategies in the Search for New Lead Compounds or Original Working Hypotheses

Bruno O. Villoutreix, Camille Georges Wermuth, Anne Olivier, 2015 .